Jennifer Bordeaux

2.3k total citations
26 papers, 1.1k citations indexed

About

Jennifer Bordeaux is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jennifer Bordeaux has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Jennifer Bordeaux's work include Cancer Immunotherapy and Biomarkers (11 papers), Advanced Biosensing Techniques and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jennifer Bordeaux is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Advanced Biosensing Techniques and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jennifer Bordeaux collaborates with scholars based in United States, Belgium and France. Jennifer Bordeaux's co-authors include David L. Rimm, Seema Agarwal, Jason A. Hanna, Allison W. Welsh, Maria T. Baquero, Valsamo Anagnostou, Veronique Neumeister, Robert L. Camp, Douglas B. Johnson and W. Kimryn Rathmell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jennifer Bordeaux

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Bordeaux United States 16 605 409 192 163 139 26 1.1k
Allison W. Welsh United States 9 442 0.7× 237 0.6× 172 0.9× 152 0.9× 65 0.5× 12 862
Ahmad Salameh United States 18 668 1.1× 340 0.8× 273 1.4× 89 0.5× 101 0.7× 24 1.1k
Jude Canon United States 21 753 1.2× 572 1.4× 126 0.7× 149 0.9× 161 1.2× 45 1.2k
Tonny Lagerweij Netherlands 20 456 0.8× 209 0.5× 129 0.7× 97 0.6× 142 1.0× 33 981
Paul J. Mintz United States 16 987 1.6× 163 0.4× 146 0.8× 236 1.4× 188 1.4× 22 1.4k
Mark N. Adams Australia 21 908 1.5× 385 0.9× 307 1.6× 52 0.3× 170 1.2× 65 1.5k
Alexei L. Krasnoselsky United States 13 591 1.0× 153 0.4× 159 0.8× 146 0.9× 168 1.2× 15 1.0k
Weijing Zhang China 22 496 0.8× 418 1.0× 251 1.3× 137 0.8× 276 2.0× 50 1.2k
Rebecca A. Worthylake United States 15 1.1k 1.8× 468 1.1× 109 0.6× 196 1.2× 309 2.2× 20 2.1k
Yixiong Zhou China 17 768 1.3× 379 0.9× 409 2.1× 291 1.8× 221 1.6× 50 1.6k

Countries citing papers authored by Jennifer Bordeaux

Since Specialization
Citations

This map shows the geographic impact of Jennifer Bordeaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Bordeaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Bordeaux more than expected).

Fields of papers citing papers by Jennifer Bordeaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Bordeaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Bordeaux. The network helps show where Jennifer Bordeaux may publish in the future.

Co-authorship network of co-authors of Jennifer Bordeaux

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Bordeaux. A scholar is included among the top collaborators of Jennifer Bordeaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Bordeaux. Jennifer Bordeaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kim, Ju‐Young, Jennifer Bordeaux, Thai H. Tran, et al.. (2020). Predictive evaluation of quantitative spatial profiling of the tumor microenvironment by multiplex immunofluorescence in recurrent glioblastoma treated with PD-1 inhibitors.. Journal of Clinical Oncology. 38(15_suppl). e14524–e14524. 1 indexed citations
3.
Franklin, Derek A., Joe T. Sharick, Paula I. González-Ericsson, et al.. (2020). MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC. JCI Insight. 5(15). 25 indexed citations
4.
Khunger, Arjun, Ghanashyam Sarikonda, Zeni Alfonso, et al.. (2020). Predictive value of circulating B cells and T cell subsets in melanoma patients treated with neoadjuvant ipilimumab and interferon.. Journal of Clinical Oncology. 38(15_suppl). e15036–e15036. 2 indexed citations
5.
Iams, Wade T., Eileen Shiuan, Catherine B. Meador, et al.. (2019). Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes. Journal of Thoracic Oncology. 14(11). 1970–1981. 56 indexed citations
6.
Bordeaux, Jennifer, Naveen Dakappagari, Nathan A. Pennell, et al.. (2018). PD-1/PD-L1 interaction and CD25/FOXP3+ t cells to predict survival benefit from adjuvant chemotherapy in early stage non–small-cell lung cancer (ES-NSCLC).. Journal of Clinical Oncology. 36(15_suppl). 12059–12059. 1 indexed citations
7.
Balko, Justin M., Douglas B. Johnson, Paula I. González-Ericsson, et al.. (2018). MHC-II expression to drive a unique pattern of adaptive resistance to antitumor immunity through receptor checkpoint engagement.. Journal of Clinical Oncology. 36(5_suppl). 180–180. 7 indexed citations
8.
Rost, Sandra, et al.. (2017). Multiplexed ion beam imaging analysis for quantitation of protein expresssion in cancer tissue sections. Laboratory Investigation. 97(8). 992–1003. 25 indexed citations
9.
Johnson, Douglas B., Jennifer Bordeaux, Ju‐Young Kim, et al.. (2017). Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM).. Journal of Clinical Oncology. 35(15_suppl). 9517–9517. 2 indexed citations
10.
Beckermann, Kathryn E., Ju Young Kim, Jennifer Bordeaux, et al.. (2017). Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma. Journal for ImmunoTherapy of Cancer. 5(1). 1–1. 58 indexed citations
11.
Bordeaux, Jennifer, Douglas B. Johnson, Jeffrey A. Sosman, et al.. (2016). Abstract 853: Novel quantitative multiplexed PD-1/PD-L1 immunohistochemistry test provides superior prediction of treatment response in melanoma patients. Cancer Research. 76(14_Supplement). 853–853. 1 indexed citations
12.
Tran, Thai H., Reshma Singh, Jennifer Bordeaux, et al.. (2015). Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials. Blood. 126(23). 2659–2659. 2 indexed citations
13.
Vassilakopoulou, Maria, Urania Dafni, Huan Cheng, et al.. (2014). In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer Patients. PLoS ONE. 9(6). e99131–e99131. 22 indexed citations
14.
Bai, Yalai, Huan Cheng, Jennifer Bordeaux, et al.. (2013). Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment Method. PLoS ONE. 8(11). e79901–e79901. 15 indexed citations
15.
Chen, Feng, Veronique Neumeister, Wei Ma, et al.. (2012). Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle. 11(13). 2486–2494. 59 indexed citations
16.
Bordeaux, Jennifer, Huan Cheng, Allison W. Welsh, et al.. (2012). Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen. PLoS ONE. 7(5). e36559–e36559. 51 indexed citations
17.
Mamoor, Shahan, Balasubramanyam Karanam, Kihyuck Kwak, et al.. (2011). The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. Virology. 422(2). 413–424. 24 indexed citations
18.
Neumeister, Veronique, Seema Agarwal, Jennifer Bordeaux, Robert L. Camp, & David L. Rimm. (2010). In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis. American Journal Of Pathology. 176(5). 2131–2138. 122 indexed citations
19.
Daley, James M., et al.. (2006). Nuclear import strategies of high-risk HPV18 L2 minor capsid protein. Virology. 352(1). 200–208. 20 indexed citations
20.
Bordeaux, Jennifer, et al.. (2006). The L2 Minor Capsid Protein of Low-Risk Human Papillomavirus Type 11 Interacts with Host Nuclear Import Receptors and Viral DNA. Journal of Virology. 80(16). 8259–8262. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026